4//SEC Filing
Cannon Louis A 4
Accession 0001387131-19-000166
CIK 0001528557other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:40 PM ET
Size
6.7 KB
Accession
0001387131-19-000166
Insider Transaction Report
Form 4
Cannon Louis A
Director
Transactions
- Award
Common Stock
2019-01-08$1.12/sh+6,808$7,625→ 251,317 total
Holdings
- 7,557,436(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. ("Corindus") Director Compensation Policy in lieu of the retainer and any meeting fees due to the reporting person in the amount of $7,625.
- [F2]Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting persons's continuous service with Corindus through each such vesting date.
- [F3]158,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- [F4]Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-l(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
Documents
Issuer
Corindus Vascular Robotics, Inc.
CIK 0001528557
Entity typeother
Related Parties
1- filerCIK 0001700257
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 5:40 PM ET
- Size
- 6.7 KB